Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Neuro-Behçet's disease: epidemiology, clinical characteristics, and managementThe Lancet Neurology, 2009
- Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activityBritish Journal of Dermatology, 2002
- Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s diseaseJournal of the Neurological Sciences, 2000
- Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patientsBrain, 1999
- Behçet's DiseaseNew England Journal of Medicine, 1999
- Behçet’s disease, the Silk Road and HLA‐B51: historical and geographical perspectivesTissue Antigens, 1999
- Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseasesMultiple Sclerosis Journal, 1998
- Cerebrospinal Fluid Interleukin-6 in Progressive Neuro-Behçet's SyndromeClinical Immunology and Immunopathology, 1997
- VALIDATION OF THE INTERNATIONAL STUDY GROUP CRITERIA FOR BEHÇET'S DISEASERheumatology, 1994
- Interferon γ- and interleukin-4-secreting cells in multiple sclerosisJournal of Neuroimmunology, 1993